Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |